Cardiac Surgical Devices Market By Product Type (Beating Heart Surgery Systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices, Perfusion Disposable), By Application (Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure, Others), By Age Group (New-born Population, Infant Population, Children Population, Adult Population): Global Opportunity Analysis and Industry Forecast, 2020-2030

Cardiac Surgical Devices Market

Cardiac surgical devices are used for the process of cardiac surgery or surgery of cardiac vessels that is performed to treat the complications of heart diseases such as valvular heart disease and congenital heart diseases. Cardiac surgical devices include stents and instruments for cardiovascular and thoracic procedures.  Cardiac surgical devices can be manual and robotic. The robotic surgical procedures result in internal injuries and have potential risk for cancer thus, manual surgeries are well opted, creating a lucrative demand for cardiac surgical devices.  

Major factors that impact the cardiac surgical devices market growth include surgeries under various fields, like open heart surgery, heart transplant, cardiac valve procedures, and coronary artery bypass graft surgery. In addition, increase in the number of patients suffering from cardiovascular diseases, owing to various factors such as obesity, diabetes, and an ageing population drives the growth of cardiac surgical devices market. However, lack of experienced healthcare professionals and lack of awareness for cardiac health procedures are some reasonable restraints that hinder the growth during cardiac surgical devices market forecast. Furthermore, government initiatives for better healthcare facilities and awareness programs in Asia-Pacific region are expected to provide lucrative growth opportunities for the market.

Coronavirus is a large family of severely acute respiratory syndrome (SARS) viruses that causes diseases ranging from common cold to severe respiratory diseases. The COVID-19 outbreak negatively impacted growth of the global cardiac surgical devices industry. Implementation of lockdown delayed the surgical procedure up to six months thereby, having a minimal negative impact on the market.

The global cardiac surgical device market is segmented on the basis of product, application, age group, and region. Depending on product type, it is classified into heart surgery systems, cardiopulmonary bypass equipment, cardiac ablation devices, and perfusion disposable. The perfusion disposable segment dominated the cardiac surgical devices market size in 2020, and is anticipated to continue this trend in the forecast, owing to the increase in prevalence of coronary artery bypass grafting and heart valve replacement surgeries.

Depending on application, the cardiac arrhythmia segment dominated the global cardiac surgical devices market share in 2020, and is anticipated to continue this trend during the forecast period, owing to increase in life expectancy and atrial fibrillation.

According to age group, the adult segment dominated the market in 2020, and is anticipated to continue this trend during cardiac surgical devices market analysis, owing to surge in lifestyle disorders.

Region wise, North America accounted for the largest share in the cardiac surgical devices market in 2020, and is expected to remain dominant throughout the forecast period. This is attributed to the growth in incidences of arrhythmia and heart failure accompanied with the rise in geriatric population and increased patient awareness about the availability of cardiac surgery options. In addition, the high adoption rate of technologically advanced devices and presence of highly sophisticated healthcare infrastructure are anticipated to bring in new growth opportunities for the key players in this market. However, Asia-Pacific is projected to grow at the highest CAGR during the analysis period, owing to rise in healthcare expenditure, increase in per capita income, and improvement in healthcare infrastructure.

KEY FINDINGS OF THE STUDY 

    Depending on product, the perfusion disposables held largest share in the global cardiac surgical devices industry in 2020.

    According to application, the cardiac arrhythmia held largest market share in 2020 and is expected to remain dominant throughout the forecast period. 

    As per age group, the adult population held largest market share in 2020 and is anticipated to continue this trend during the forecast period.

    Region wise, North America is expected to experience growth at the highest rate in cardiac surgical devices market size, registering a CAGR of 2.9% during the forecast period.

Overview

The global cardiac surgical devices market was valued at $2,208.73 million in 2020 and is projected to reach $3052.38 million by 2030, registering a CAGR of 3.3% from 2021 to 2030. 

Cardiac surgery is the process performed to cure heart tissue defects, such as replacing the diseased heart valves (if blocked), grafting, or replacement of heart tissues in case of damage. There are two major types of heart surgeries performed—closed and open. Cardiac surgical devices are used for angioplasty, valve replacements, stent placement, and open heart surgery. 

Factors that drive the growth of cardiac surgical devices market are increase in health and lifestyle disorders, rise in the prevalence of cardiovascular diseases, surge in the geriatric population with rising co-morbidities, increase in sedentary lifestyles, rise in excessive cigarette use, surge in number of diabetic patients, and increase in the number of people suffering from obesity. Increase in number of people suffering from vascular malfunctions and congenital defects as well as rise in the number of people suffering from poor nutrition as a result of changing lifestyles and an increase in the obese population, are expected to drive the growth of cardiovascular surgical devices market. However, in the developing and undeveloped countries, there are economic limits associated with these devices, as well as lack of experienced personnel.

The global cardiac surgical devices market is segmented on the basis of product, application, and age group. Based on product type, it is fragmented into beating heart surgery systems, cardiopulmonary bypass equipment, cardiac ablation devices, and perfusion disposable. Depending on application, it is categorized into congenital heart defects, cardiac arrhythmia, coronary heart disease, and congestive heart failure. On the basis of age group, it is categorized into, new-born, infant, children, and adults. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key market players profiled in the report include includes Edwards Life Science Corporation, Medtronic Inc., Getinge Group, Atrion Corporation, Abbott Laboratories, Sorin S.P.A., Terumo Medical Corporation, Boston Scientific Corporation, Cook Medical, and Angiodynamics, Inc.

 

Key Market Segments

LIVANOVA, PL

Scope of Cardiac Surgical Devices Market Report

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

4.1 Overview

4.1.1 Market size and forecast

4.2 Beating Heart Surgery Systems

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market analysis by country

4.3 Cardiopulmonary Bypass Equipment

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market analysis by country

4.4 Cardiac Ablation Devices

4.4.1 Key market trends, growth factors and opportunities

4.4.2 Market size and forecast, by region

4.4.3 Market analysis by country

4.5 Perfusion Disposable

4.5.1 Key market trends, growth factors and opportunities

4.5.2 Market size and forecast, by region

4.5.3 Market analysis by country

5.1 Overview

5.1.1 Market size and forecast

5.2 Congenital Heart Defects

5.2.1 Key market trends, growth factors and opportunities

5.2.2 Market size and forecast, by region

5.2.3 Market analysis by country

5.3 Cardiac Arrhythmia

5.3.1 Key market trends, growth factors and opportunities

5.3.2 Market size and forecast, by region

5.3.3 Market analysis by country

5.4 Coronary Heart Disease

5.4.1 Key market trends, growth factors and opportunities

5.4.2 Market size and forecast, by region

5.4.3 Market analysis by country

5.5 Congestive Heart Failure

5.5.1 Key market trends, growth factors and opportunities

5.5.2 Market size and forecast, by region

5.5.3 Market analysis by country

5.6 Others

5.6.1 Key market trends, growth factors and opportunities

5.6.2 Market size and forecast, by region

5.6.3 Market analysis by country

6.1 Overview

6.1.1 Market size and forecast

6.2 New-born Population

6.2.1 Key market trends, growth factors and opportunities

6.2.2 Market size and forecast, by region

6.2.3 Market analysis by country

6.3 Infant Population

6.3.1 Key market trends, growth factors and opportunities

6.3.2 Market size and forecast, by region

6.3.3 Market analysis by country

6.4 Children Population

6.4.1 Key market trends, growth factors and opportunities

6.4.2 Market size and forecast, by region

6.4.3 Market analysis by country

6.5 Adult Population

6.5.1 Key market trends, growth factors and opportunities

6.5.2 Market size and forecast, by region

6.5.3 Market analysis by country

7.1 Overview

7.1.1 Market size and forecast

7.2 North America

7.2.1 Key trends and opportunities

7.2.2 North America Market size and forecast, by Product Type

7.2.3 North America Market size and forecast, by Application

7.2.4 North America Market size and forecast, by Age Group

7.2.5 North America Market size and forecast, by country

7.2.5.1 U.S.

7.2.5.1.1 Market size and forecast, by Product Type

7.2.5.1.2 Market size and forecast, by Application

7.2.5.1.3 Market size and forecast, by Age Group

7.2.5.2 Canada

7.2.5.2.1 Market size and forecast, by Product Type

7.2.5.2.2 Market size and forecast, by Application

7.2.5.2.3 Market size and forecast, by Age Group

7.2.5.3 Mexico

7.2.5.3.1 Market size and forecast, by Product Type

7.2.5.3.2 Market size and forecast, by Application

7.2.5.3.3 Market size and forecast, by Age Group

7.3 Europe

7.3.1 Key trends and opportunities

7.3.2 Europe Market size and forecast, by Product Type

7.3.3 Europe Market size and forecast, by Application

7.3.4 Europe Market size and forecast, by Age Group

7.3.5 Europe Market size and forecast, by country

7.3.5.1 Germany

7.3.5.1.1 Market size and forecast, by Product Type

7.3.5.1.2 Market size and forecast, by Application

7.3.5.1.3 Market size and forecast, by Age Group

7.3.5.2 France

7.3.5.2.1 Market size and forecast, by Product Type

7.3.5.2.2 Market size and forecast, by Application

7.3.5.2.3 Market size and forecast, by Age Group

7.3.5.3 U.K.

7.3.5.3.1 Market size and forecast, by Product Type

7.3.5.3.2 Market size and forecast, by Application

7.3.5.3.3 Market size and forecast, by Age Group

7.3.5.4 Italy

7.3.5.4.1 Market size and forecast, by Product Type

7.3.5.4.2 Market size and forecast, by Application

7.3.5.4.3 Market size and forecast, by Age Group

7.3.5.5 Spain

7.3.5.5.1 Market size and forecast, by Product Type

7.3.5.5.2 Market size and forecast, by Application

7.3.5.5.3 Market size and forecast, by Age Group

7.3.5.6 Rest of Europe

7.3.5.6.1 Market size and forecast, by Product Type

7.3.5.6.2 Market size and forecast, by Application

7.3.5.6.3 Market size and forecast, by Age Group

7.4 Asia-Pacific

7.4.1 Key trends and opportunities

7.4.2 Asia-Pacific Market size and forecast, by Product Type

7.4.3 Asia-Pacific Market size and forecast, by Application

7.4.4 Asia-Pacific Market size and forecast, by Age Group

7.4.5 Asia-Pacific Market size and forecast, by country

7.4.5.1 Japan

7.4.5.1.1 Market size and forecast, by Product Type

7.4.5.1.2 Market size and forecast, by Application

7.4.5.1.3 Market size and forecast, by Age Group

7.4.5.2 China

7.4.5.2.1 Market size and forecast, by Product Type

7.4.5.2.2 Market size and forecast, by Application

7.4.5.2.3 Market size and forecast, by Age Group

7.4.5.3 India

7.4.5.3.1 Market size and forecast, by Product Type

7.4.5.3.2 Market size and forecast, by Application

7.4.5.3.3 Market size and forecast, by Age Group

7.4.5.4 Australia

7.4.5.4.1 Market size and forecast, by Product Type

7.4.5.4.2 Market size and forecast, by Application

7.4.5.4.3 Market size and forecast, by Age Group

7.4.5.5 South Korea

7.4.5.5.1 Market size and forecast, by Product Type

7.4.5.5.2 Market size and forecast, by Application

7.4.5.5.3 Market size and forecast, by Age Group

7.4.5.6 Rest of Asia-Pacific

7.4.5.6.1 Market size and forecast, by Product Type

7.4.5.6.2 Market size and forecast, by Application

7.4.5.6.3 Market size and forecast, by Age Group

7.5 LAMEA

7.5.1 Key trends and opportunities

7.5.2 LAMEA Market size and forecast, by Product Type

7.5.3 LAMEA Market size and forecast, by Application

7.5.4 LAMEA Market size and forecast, by Age Group

7.5.5 LAMEA Market size and forecast, by country

7.5.5.1 Brazil

7.5.5.1.1 Market size and forecast, by Product Type

7.5.5.1.2 Market size and forecast, by Application

7.5.5.1.3 Market size and forecast, by Age Group

7.5.5.2 Saudi Arabia

7.5.5.2.1 Market size and forecast, by Product Type

7.5.5.2.2 Market size and forecast, by Application

7.5.5.2.3 Market size and forecast, by Age Group

7.5.5.3 South Africa

7.5.5.3.1 Market size and forecast, by Product Type

7.5.5.3.2 Market size and forecast, by Application

7.5.5.3.3 Market size and forecast, by Age Group

7.5.5.4 Rest of LAMEA

7.5.5.4.1 Market size and forecast, by Product Type

7.5.5.4.2 Market size and forecast, by Application

7.5.5.4.3 Market size and forecast, by Age Group

8.1. Introduction

8.2. Top winning strategies

8.3. Product Mapping of Top 10 Player

8.4. Competitive Dashboard

8.5. Competitive Heatmap

8.6. Key developments

9.1 ABBOTT LABORATORIES

9.1.1 Company overview

9.1.2 Company snapshot

9.1.3 Operating business segments

9.1.4 Product portfolio

9.1.5 Business performance

9.1.6 Key strategic moves and developments

9.2 ANGIODYNAMICS, INC.

9.2.1 Company overview

9.2.2 Company snapshot

9.2.3 Operating business segments

9.2.4 Product portfolio

9.2.5 Business performance

9.2.6 Key strategic moves and developments

9.3 ATRION CORPORATION

9.3.1 Company overview

9.3.2 Company snapshot

9.3.3 Operating business segments

9.3.4 Product portfolio

9.3.5 Business performance

9.3.6 Key strategic moves and developments

9.4 BOSTON SCIENTIFIC CORPORATION

9.4.1 Company overview

9.4.2 Company snapshot

9.4.3 Operating business segments

9.4.4 Product portfolio

9.4.5 Business performance

9.4.6 Key strategic moves and developments

9.5 COOK GROUP

9.5.1 Company overview

9.5.2 Company snapshot

9.5.3 Operating business segments

9.5.4 Product portfolio

9.5.5 Business performance

9.5.6 Key strategic moves and developments

9.6 EDWARD LIFESCIENCES CORPORATION

9.6.1 Company overview

9.6.2 Company snapshot

9.6.3 Operating business segments

9.6.4 Product portfolio

9.6.5 Business performance

9.6.6 Key strategic moves and developments

9.7 GETINGE AB

9.7.1 Company overview

9.7.2 Company snapshot

9.7.3 Operating business segments

9.7.4 Product portfolio

9.7.5 Business performance

9.7.6 Key strategic moves and developments

9.8 MEDTRONIC PLC

9.8.1 Company overview

9.8.2 Company snapshot

9.8.3 Operating business segments

9.8.4 Product portfolio

9.8.5 Business performance

9.8.6 Key strategic moves and developments

9.9 TERUMO CORPORATION

9.9.1 Company overview

9.9.2 Company snapshot

9.9.3 Operating business segments

9.9.4 Product portfolio

9.9.5 Business performance

9.9.6 Key strategic moves and developments

9.10 LIVANOVA, PLC

9.10.1 Company overview

9.10.2 Company snapshot

9.10.3 Operating business segments

9.10.4 Product portfolio

9.10.5 Business performance

9.10.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL CARDIAC SURGICAL DEVICES MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)

TABLE 2. CARDIAC SURGICAL DEVICES MARKET REVENUE, FOR BEATING HEART SURGERY SYSTEMS, BY REGION , 2020-2030,($MILLION)

TABLE 3. CARDIAC SURGICAL DEVICES MARKET BEATING HEART SURGERY SYSTEMS BY COUNTRY, 2020-2030,($MILLION)

TABLE 4. CARDIAC SURGICAL DEVICES MARKET REVENUE, FOR CARDIOPULMONARY BYPASS EQUIPMENT, BY REGION , 2020-2030,($MILLION)

TABLE 5. CARDIAC SURGICAL DEVICES MARKET CARDIOPULMONARY BYPASS EQUIPMENT BY COUNTRY, 2020-2030,($MILLION)

TABLE 6. CARDIAC SURGICAL DEVICES MARKET REVENUE, FOR CARDIAC ABLATION DEVICES, BY REGION , 2020-2030,($MILLION)

TABLE 7. CARDIAC SURGICAL DEVICES MARKET CARDIAC ABLATION DEVICES BY COUNTRY, 2020-2030,($MILLION)

TABLE 8. CARDIAC SURGICAL DEVICES MARKET REVENUE, FOR PERFUSION DISPOSABLE, BY REGION , 2020-2030,($MILLION)

TABLE 9. CARDIAC SURGICAL DEVICES MARKET PERFUSION DISPOSABLE BY COUNTRY, 2020-2030,($MILLION)

TABLE 10. GLOBAL CARDIAC SURGICAL DEVICES MARKET, BY APPLICATION, 2020-2030,($MILLION)

TABLE 11. CARDIAC SURGICAL DEVICES MARKET REVENUE, FOR CONGENITAL HEART DEFECTS, BY REGION , 2020-2030,($MILLION)

TABLE 12. CARDIAC SURGICAL DEVICES MARKET CONGENITAL HEART DEFECTS BY COUNTRY, 2020-2030,($MILLION)

TABLE 13. CARDIAC SURGICAL DEVICES MARKET REVENUE, FOR CARDIAC ARRHYTHMIA, BY REGION , 2020-2030,($MILLION)

TABLE 14. CARDIAC SURGICAL DEVICES MARKET CARDIAC ARRHYTHMIA BY COUNTRY, 2020-2030,($MILLION)

TABLE 15. CARDIAC SURGICAL DEVICES MARKET REVENUE, FOR CORONARY HEART DISEASE, BY REGION , 2020-2030,($MILLION)

TABLE 16. CARDIAC SURGICAL DEVICES MARKET CORONARY HEART DISEASE BY COUNTRY, 2020-2030,($MILLION)

TABLE 17. CARDIAC SURGICAL DEVICES MARKET REVENUE, FOR CONGESTIVE HEART FAILURE, BY REGION , 2020-2030,($MILLION)

TABLE 18. CARDIAC SURGICAL DEVICES MARKET CONGESTIVE HEART FAILURE BY COUNTRY, 2020-2030,($MILLION)

TABLE 19. CARDIAC SURGICAL DEVICES MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)

TABLE 20. CARDIAC SURGICAL DEVICES MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)

TABLE 21. GLOBAL CARDIAC SURGICAL DEVICES MARKET, BY AGE GROUP, 2020-2030,($MILLION)

TABLE 22. CARDIAC SURGICAL DEVICES MARKET REVENUE, FOR NEW-BORN POPULATION, BY REGION , 2020-2030,($MILLION)

TABLE 23. CARDIAC SURGICAL DEVICES MARKET NEW-BORN POPULATION BY COUNTRY, 2020-2030,($MILLION)

TABLE 24. CARDIAC SURGICAL DEVICES MARKET REVENUE, FOR INFANT POPULATION, BY REGION , 2020-2030,($MILLION)

TABLE 25. CARDIAC SURGICAL DEVICES MARKET INFANT POPULATION BY COUNTRY, 2020-2030,($MILLION)

TABLE 26. CARDIAC SURGICAL DEVICES MARKET REVENUE, FOR CHILDREN POPULATION, BY REGION , 2020-2030,($MILLION)

TABLE 27. CARDIAC SURGICAL DEVICES MARKET CHILDREN POPULATION BY COUNTRY, 2020-2030,($MILLION)

TABLE 28. CARDIAC SURGICAL DEVICES MARKET REVENUE, FOR ADULT POPULATION, BY REGION , 2020-2030,($MILLION)

TABLE 29. CARDIAC SURGICAL DEVICES MARKET ADULT POPULATION BY COUNTRY, 2020-2030,($MILLION)

TABLE 30. CARDIAC SURGICAL DEVICES MARKET, BY REGION, 2020-2030,($MILLION)

TABLE 31. NORTH AMERICA CARDIAC SURGICAL DEVICES MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)

TABLE 32. NORTH AMERICA CARDIAC SURGICAL DEVICES MARKET, BY APPLICATION, 2020-2030,($MILLION)

TABLE 33. NORTH AMERICA CARDIAC SURGICAL DEVICES MARKET, BY AGE GROUP, 2020-2030,($MILLION)

TABLE 34. NORTH AMERICA CARDIAC SURGICAL DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 35. U.S. CARDIAC SURGICAL DEVICES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)

TABLE 36. U.S. CARDIAC SURGICAL DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 37. U.S. CARDIAC SURGICAL DEVICES MARKET BY AGE GROUP 2020-2030,($MILLION)

TABLE 38. CANADA CARDIAC SURGICAL DEVICES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)

TABLE 39. CANADA CARDIAC SURGICAL DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 40. CANADA CARDIAC SURGICAL DEVICES MARKET BY AGE GROUP 2020-2030,($MILLION)

TABLE 41. MEXICO CARDIAC SURGICAL DEVICES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)

TABLE 42. MEXICO CARDIAC SURGICAL DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 43. MEXICO CARDIAC SURGICAL DEVICES MARKET BY AGE GROUP 2020-2030,($MILLION)

TABLE 44. EUROPE CARDIAC SURGICAL DEVICES MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)

TABLE 45. EUROPE CARDIAC SURGICAL DEVICES MARKET, BY APPLICATION, 2020-2030,($MILLION)

TABLE 46. EUROPE CARDIAC SURGICAL DEVICES MARKET, BY AGE GROUP, 2020-2030,($MILLION)

TABLE 47. EUROPE CARDIAC SURGICAL DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 48. GERMANY CARDIAC SURGICAL DEVICES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)

TABLE 49. GERMANY CARDIAC SURGICAL DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 50. GERMANY CARDIAC SURGICAL DEVICES MARKET BY AGE GROUP 2020-2030,($MILLION)

TABLE 51. FRANCE CARDIAC SURGICAL DEVICES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)

TABLE 52. FRANCE CARDIAC SURGICAL DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 53. FRANCE CARDIAC SURGICAL DEVICES MARKET BY AGE GROUP 2020-2030,($MILLION)

TABLE 54. U.K. CARDIAC SURGICAL DEVICES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)

TABLE 55. U.K. CARDIAC SURGICAL DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 56. U.K. CARDIAC SURGICAL DEVICES MARKET BY AGE GROUP 2020-2030,($MILLION)

TABLE 57. ITALY CARDIAC SURGICAL DEVICES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)

TABLE 58. ITALY CARDIAC SURGICAL DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 59. ITALY CARDIAC SURGICAL DEVICES MARKET BY AGE GROUP 2020-2030,($MILLION)

TABLE 60. SPAIN CARDIAC SURGICAL DEVICES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)

TABLE 61. SPAIN CARDIAC SURGICAL DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 62. SPAIN CARDIAC SURGICAL DEVICES MARKET BY AGE GROUP 2020-2030,($MILLION)

TABLE 63. REST OF EUROPE CARDIAC SURGICAL DEVICES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)

TABLE 64. REST OF EUROPE CARDIAC SURGICAL DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 65. REST OF EUROPE CARDIAC SURGICAL DEVICES MARKET BY AGE GROUP 2020-2030,($MILLION)

TABLE 66. ASIA-PACIFIC CARDIAC SURGICAL DEVICES MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)

TABLE 67. ASIA-PACIFIC CARDIAC SURGICAL DEVICES MARKET, BY APPLICATION, 2020-2030,($MILLION)

TABLE 68. ASIA-PACIFIC CARDIAC SURGICAL DEVICES MARKET, BY AGE GROUP, 2020-2030,($MILLION)

TABLE 69. ASIA-PACIFIC CARDIAC SURGICAL DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 70. JAPAN CARDIAC SURGICAL DEVICES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)

TABLE 71. JAPAN CARDIAC SURGICAL DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 72. JAPAN CARDIAC SURGICAL DEVICES MARKET BY AGE GROUP 2020-2030,($MILLION)

TABLE 73. CHINA CARDIAC SURGICAL DEVICES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)

TABLE 74. CHINA CARDIAC SURGICAL DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 75. CHINA CARDIAC SURGICAL DEVICES MARKET BY AGE GROUP 2020-2030,($MILLION)

TABLE 76. INDIA CARDIAC SURGICAL DEVICES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)

TABLE 77. INDIA CARDIAC SURGICAL DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 78. INDIA CARDIAC SURGICAL DEVICES MARKET BY AGE GROUP 2020-2030,($MILLION)

TABLE 79. AUSTRALIA CARDIAC SURGICAL DEVICES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)

TABLE 80. AUSTRALIA CARDIAC SURGICAL DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 81. AUSTRALIA CARDIAC SURGICAL DEVICES MARKET BY AGE GROUP 2020-2030,($MILLION)

TABLE 82. SOUTH KOREA CARDIAC SURGICAL DEVICES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)

TABLE 83. SOUTH KOREA CARDIAC SURGICAL DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 84. SOUTH KOREA CARDIAC SURGICAL DEVICES MARKET BY AGE GROUP 2020-2030,($MILLION)

TABLE 85. REST OF ASIA-PACIFIC CARDIAC SURGICAL DEVICES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)

TABLE 86. REST OF ASIA-PACIFIC CARDIAC SURGICAL DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 87. REST OF ASIA-PACIFIC CARDIAC SURGICAL DEVICES MARKET BY AGE GROUP 2020-2030,($MILLION)

TABLE 88. LAMEA CARDIAC SURGICAL DEVICES MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)

TABLE 89. LAMEA CARDIAC SURGICAL DEVICES MARKET, BY APPLICATION, 2020-2030,($MILLION)

TABLE 90. LAMEA CARDIAC SURGICAL DEVICES MARKET, BY AGE GROUP, 2020-2030,($MILLION)

TABLE 91. LAMEA CARDIAC SURGICAL DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 92. BRAZIL CARDIAC SURGICAL DEVICES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)

TABLE 93. BRAZIL CARDIAC SURGICAL DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 94. BRAZIL CARDIAC SURGICAL DEVICES MARKET BY AGE GROUP 2020-2030,($MILLION)

TABLE 95. SAUDI ARABIA CARDIAC SURGICAL DEVICES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)

TABLE 96. SAUDI ARABIA CARDIAC SURGICAL DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 97. SAUDI ARABIA CARDIAC SURGICAL DEVICES MARKET BY AGE GROUP 2020-2030,($MILLION)

TABLE 98. SOUTH AFRICA CARDIAC SURGICAL DEVICES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)

TABLE 99. SOUTH AFRICA CARDIAC SURGICAL DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 100. SOUTH AFRICA CARDIAC SURGICAL DEVICES MARKET BY AGE GROUP 2020-2030,($MILLION)

TABLE 101. REST OF LAMEA CARDIAC SURGICAL DEVICES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)

TABLE 102. REST OF LAMEA CARDIAC SURGICAL DEVICES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 103. REST OF LAMEA CARDIAC SURGICAL DEVICES MARKET BY AGE GROUP 2020-2030,($MILLION)

TABLE 104.ABBOTT LABORATORIES: COMPANY SNAPSHOT

TABLE 105.ABBOTT LABORATORIES: OPERATING SEGMENTS

TABLE 106.ABBOTT LABORATORIES: PRODUCT PORTFOLIO

TABLE 107.ABBOTT LABORATORIES: NET SALES,

TABLE 108.ABBOTT LABORATORIES: KEY STRATERGIES

TABLE 109.ANGIODYNAMICS, INC.: COMPANY SNAPSHOT

TABLE 110.ANGIODYNAMICS, INC.: OPERATING SEGMENTS

TABLE 111.ANGIODYNAMICS, INC.: PRODUCT PORTFOLIO

TABLE 112.ANGIODYNAMICS, INC.: NET SALES,

TABLE 113.ANGIODYNAMICS, INC.: KEY STRATERGIES

TABLE 114.ATRION CORPORATION: COMPANY SNAPSHOT

TABLE 115.ATRION CORPORATION: OPERATING SEGMENTS

TABLE 116.ATRION CORPORATION: PRODUCT PORTFOLIO

TABLE 117.ATRION CORPORATION: NET SALES,

TABLE 118.ATRION CORPORATION: KEY STRATERGIES

TABLE 119.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT

TABLE 120.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS

TABLE 121.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO

TABLE 122.BOSTON SCIENTIFIC CORPORATION: NET SALES,

TABLE 123.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES

TABLE 124.COOK GROUP: COMPANY SNAPSHOT

TABLE 125.COOK GROUP: OPERATING SEGMENTS

TABLE 126.COOK GROUP: PRODUCT PORTFOLIO

TABLE 127.COOK GROUP: NET SALES,

TABLE 128.COOK GROUP: KEY STRATERGIES

TABLE 129.EDWARD LIFESCIENCES CORPORATION: COMPANY SNAPSHOT

TABLE 130.EDWARD LIFESCIENCES CORPORATION: OPERATING SEGMENTS

TABLE 131.EDWARD LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO

TABLE 132.EDWARD LIFESCIENCES CORPORATION: NET SALES,

TABLE 133.EDWARD LIFESCIENCES CORPORATION: KEY STRATERGIES

TABLE 134.GETINGE AB: COMPANY SNAPSHOT

TABLE 135.GETINGE AB: OPERATING SEGMENTS

TABLE 136.GETINGE AB: PRODUCT PORTFOLIO

TABLE 137.GETINGE AB: NET SALES,

TABLE 138.GETINGE AB: KEY STRATERGIES

TABLE 139.MEDTRONIC PLC: COMPANY SNAPSHOT

TABLE 140.MEDTRONIC PLC: OPERATING SEGMENTS

TABLE 141.MEDTRONIC PLC: PRODUCT PORTFOLIO

TABLE 142.MEDTRONIC PLC: NET SALES,

TABLE 143.MEDTRONIC PLC: KEY STRATERGIES

TABLE 144.TERUMO CORPORATION: COMPANY SNAPSHOT

TABLE 145.TERUMO CORPORATION: OPERATING SEGMENTS

TABLE 146.TERUMO CORPORATION: PRODUCT PORTFOLIO

TABLE 147.TERUMO CORPORATION: NET SALES,

TABLE 148.TERUMO CORPORATION: KEY STRATERGIES

TABLE 149.LIVANOVA, PLC: COMPANY SNAPSHOT

TABLE 150.LIVANOVA, PLC: OPERATING SEGMENTS

TABLE 151.LIVANOVA, PLC: PRODUCT PORTFOLIO

TABLE 152.LIVANOVA, PLC: NET SALES,

TABLE 153.LIVANOVA, PLC: KEY STRATERGIES LIST OF FIGURES

FIGURE 1.CARDIAC SURGICAL DEVICES MARKET SEGMENTATION

FIGURE 2.CARDIAC SURGICAL DEVICES MARKET,2020-2030

FIGURE 3.CARDIAC SURGICAL DEVICES MARKET,2020-2030

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.CARDIAC SURGICAL DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 11.CARDIAC SURGICAL DEVICES MARKET,BY PRODUCT TYPE,2020(%)

FIGURE 12.COMPARATIVE SHARE ANALYSIS OF BEATING HEART SURGERY SYSTEMS CARDIAC SURGICAL DEVICES MARKET,2020-2030(%)

FIGURE 13.COMPARATIVE SHARE ANALYSIS OF CARDIOPULMONARY BYPASS EQUIPMENT CARDIAC SURGICAL DEVICES MARKET,2020-2030(%)

FIGURE 14.COMPARATIVE SHARE ANALYSIS OF CARDIAC ABLATION DEVICES CARDIAC SURGICAL DEVICES MARKET,2020-2030(%)

FIGURE 15.COMPARATIVE SHARE ANALYSIS OF PERFUSION DISPOSABLE CARDIAC SURGICAL DEVICES MARKET,2020-2030(%)

FIGURE 16.CARDIAC SURGICAL DEVICES MARKET,BY APPLICATION,2020(%)

FIGURE 17.COMPARATIVE SHARE ANALYSIS OF CONGENITAL HEART DEFECTS CARDIAC SURGICAL DEVICES MARKET,2020-2030(%)

FIGURE 18.COMPARATIVE SHARE ANALYSIS OF CARDIAC ARRHYTHMIA CARDIAC SURGICAL DEVICES MARKET,2020-2030(%)

FIGURE 19.COMPARATIVE SHARE ANALYSIS OF CORONARY HEART DISEASE CARDIAC SURGICAL DEVICES MARKET,2020-2030(%)

FIGURE 20.COMPARATIVE SHARE ANALYSIS OF CONGESTIVE HEART FAILURE CARDIAC SURGICAL DEVICES MARKET,2020-2030(%)

FIGURE 21.COMPARATIVE SHARE ANALYSIS OF OTHERS CARDIAC SURGICAL DEVICES MARKET,2020-2030(%)

FIGURE 22.CARDIAC SURGICAL DEVICES MARKET,BY AGE GROUP,2020(%)

FIGURE 23.COMPARATIVE SHARE ANALYSIS OF NEW-BORN POPULATION CARDIAC SURGICAL DEVICES MARKET,2020-2030(%)

FIGURE 24.COMPARATIVE SHARE ANALYSIS OF INFANT POPULATION CARDIAC SURGICAL DEVICES MARKET,2020-2030(%)

FIGURE 25.COMPARATIVE SHARE ANALYSIS OF CHILDREN POPULATION CARDIAC SURGICAL DEVICES MARKET,2020-2030(%)

FIGURE 26.COMPARATIVE SHARE ANALYSIS OF ADULT POPULATION CARDIAC SURGICAL DEVICES MARKET,2020-2030(%)

FIGURE 27.CARDIAC SURGICAL DEVICES MARKET BY REGION,2020

FIGURE 28.U.S. CARDIAC SURGICAL DEVICES MARKET,2020-2030($MILLION)

FIGURE 29.CANADA CARDIAC SURGICAL DEVICES MARKET,2020-2030($MILLION)

FIGURE 30.MEXICO CARDIAC SURGICAL DEVICES MARKET,2020-2030($MILLION)

FIGURE 31.GERMANY CARDIAC SURGICAL DEVICES MARKET,2020-2030($MILLION)

FIGURE 32.FRANCE CARDIAC SURGICAL DEVICES MARKET,2020-2030($MILLION)

FIGURE 33.U.K. CARDIAC SURGICAL DEVICES MARKET,2020-2030($MILLION)

FIGURE 34.ITALY CARDIAC SURGICAL DEVICES MARKET,2020-2030($MILLION)

FIGURE 35.SPAIN CARDIAC SURGICAL DEVICES MARKET,2020-2030($MILLION)

FIGURE 36.REST OF EUROPE CARDIAC SURGICAL DEVICES MARKET,2020-2030($MILLION)

FIGURE 37.JAPAN CARDIAC SURGICAL DEVICES MARKET,2020-2030($MILLION)

FIGURE 38.CHINA CARDIAC SURGICAL DEVICES MARKET,2020-2030($MILLION)

FIGURE 39.INDIA CARDIAC SURGICAL DEVICES MARKET,2020-2030($MILLION)

FIGURE 40.AUSTRALIA CARDIAC SURGICAL DEVICES MARKET,2020-2030($MILLION)

FIGURE 41.SOUTH KOREA CARDIAC SURGICAL DEVICES MARKET,2020-2030($MILLION)

FIGURE 42.REST OF ASIA-PACIFIC CARDIAC SURGICAL DEVICES MARKET,2020-2030($MILLION)

FIGURE 43.BRAZIL CARDIAC SURGICAL DEVICES MARKET,2020-2030($MILLION)

FIGURE 44.SAUDI ARABIA CARDIAC SURGICAL DEVICES MARKET,2020-2030($MILLION)

FIGURE 45.SOUTH AFRICA CARDIAC SURGICAL DEVICES MARKET,2020-2030($MILLION)

FIGURE 46.REST OF LAMEA CARDIAC SURGICAL DEVICES MARKET,2020-2030($MILLION)

FIGURE 47. TOP WINNING STRATEGIES, BY YEAR

FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 50.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 51.COMPETITIVE DASHBOARD

FIGURE 52.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 53.ABBOTT LABORATORIES.: NET SALES ,($MILLION)

FIGURE 54.ANGIODYNAMICS, INC..: NET SALES ,($MILLION)

FIGURE 55.ATRION CORPORATION.: NET SALES ,($MILLION)

FIGURE 56.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)

FIGURE 57.COOK GROUP.: NET SALES ,($MILLION)

FIGURE 58.EDWARD LIFESCIENCES CORPORATION.: NET SALES ,($MILLION)

FIGURE 59.GETINGE AB.: NET SALES ,($MILLION)

FIGURE 60.MEDTRONIC PLC.: NET SALES ,($MILLION)

FIGURE 61.TERUMO CORPORATION.: NET SALES ,($MILLION)

FIGURE 62.LIVANOVA, PLC.: NET SALES ,($MILLION